Clinical management of patients with moderate to severe COVID-19 - Interim guidance

Clinical management of patients with moderate to severe COVID-19 - Interim guidance This guidance has been adapted for Canadian use from the WHO document entitled "Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected – Interim guidance - 13 March 2020". This guidance is informed by currently available scientific evidence and expert opinion, and is subject to change as new information becomes available. 2021-10-29 Public Health Agency of Canada open-ouvert@tbs-sct.gc.ca Health and SafetyClinical managementof patientswith COVID-19Clinical managementinterim guidance. Clinical management of patients with moderate to severe COVID-19 - Interim guidancePDF https://www.cfpc.ca/CFPC/media/PDF/AMMI-CCCS-PHAC-clinical-guidance-Aug21-EN-FINAL.pdf Clinical management of patients with moderate to severe COVID-19 - Interim guidancePDF https://www.cfpc.ca/CFPC/media/PDF/AMMI-CCCS-PHAC-clinical-guidance-Aug21-FR-FINAL.pdf

This guidance has been adapted for Canadian use from the WHO document entitled "Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected – Interim guidance - 13 March 2020". This guidance is informed by currently available scientific evidence and expert opinion, and is subject to change as new information becomes available.

Data and Resources

Similar records